Toggle navigation
Home
Search
Services
Blog
Contact
About
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - WSn68 - ZILEUT-261005022
Wayne State University, Detroit, MI, United States
Search grants from Wayne State University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The role of lysine acetylation of human threonyl-tRNA synthetase
Beat to beat Ca2+-dependent regulation of pacemaker cell rate and rhythm
Environment & Genetics of Monoclonal Gammopathy of Uncertain Significance (MGUS)
Training in Use of 2d Gels
Neurobiologic Studies of Neurons and Glia in Cell Culture
Recently added grants:
Hepatitis C Virus Trafficking in Hepatocytes
Discovering the Immunologic Mechanism of Ascaris-induced Allergic Airway Disease.
New tools for antimalarial target identification
Alterations in the surfaceome of the herpes simplex virus 1 infected cells via the Cbl/CIN85 endocytic machinery and the role of the Infected Cell Protein No 0 (ICP0) in endocytosis.
Detection and Activation of CD4+ T cells with Low Affinity TCRs
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN005022-003
Application #
7329487
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2006
Total Cost
Indirect Cost
Institution
Name
Wayne State University
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Related projects
NIH 2006
N01 CN
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - WSn68 - ZILEUT-261005022
/ Wayne State University
NIH 2004
N01 CN
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - WSn68 - ZILEUT-261005022
/ Wayne State University
NIH 2000
N01 CN
Phase II Clinial Trial of New Chemopreventive Agents - W
Kucuk, Omer / Wayne State University
$758,959
Comments
Be the first to comment on this grant